LINCOLN

Lincoln Pharma notched 42% higher Q4 EPS of Rs 6.3 and 21% higher FY21 EPS of Rs 31 is the cheapest pharma share. With likely EPS of Rs 38, the share trades at a forward P/E of 9x.
Lincoln Pharma has entered the fast track. The Company is now debt free and has aggressive expansion programs. Rising exports and strong financials make this share a good buy. Will be a great buy near 315-320 levels.